Catalog No.
Product Name
Application
Product Information
Citations
-
Bacterial Carbon Source
3-Methylvaleric Acid is a branched alkanoic acid that serves as a sole carbon source for the growth of Pseudomonas citronettotis. This compound is essential in microbiological studies focused on bacterial metabolism and can be used to investigate microbial responses to carbon availability. Additionally, derivatives of 3-Methylvaleric Acid demonstrate anti-hyperalgesic and anticonvulsant activities, making it relevant for pharmacological research. -
Bacterial Inhibitor
Hetacillin is a beta-lactam antibiotic that acts primarily by inhibiting bacterial cell wall synthesis. As a member of the aminopenicillin family, it is effective against a variety of gram-positive and some gram-negative bacteria. This reagent is commonly utilized in microbiological studies and antibiotic susceptibility testing, making it valuable for research on bacterial infections and resistance mechanisms. -
Antibacterial Agent
Erinacine P is a cyathane-type diterpenoid with antibacterial properties. Isolated from the mycelia and submerged cultures of Hericium erinaceum, it serves as a precursor for producing biologically active compounds, including Erinacine C, A, and B. Erinacine P demonstrates notable antibacterial efficacy against Aliivibrio fischeri, making it a valuable candidate for research applications focused on bacterial infections and antimicrobial mechanisms. -
Antibacterial Agent
Antibacterial Agent 268 is an effective antibacterial compound that specifically targets mycobacterial pathogens. It demonstrates potent antibacterial activity, with a minimum inhibitory concentration (MIC) ranging from 0.44 to 0.07 μM. This compound is applicable in research focused on the development of antimicrobial therapies and the study of mycobacterial infections. -
Antibacterial Agent
Fobrepodacin disodium is an orally active phosphate proagent that converts to the active compound SPR719. It exhibits potent bactericidal activity in vivo, making it a valuable tool for antibacterial research. This compound is suitable for studies investigating the mechanisms of antibacterial efficacy and resistance in various bacterial strains. -
Bacterial β-glucuronidase Inhibitor
UNC10201652 is a potent inhibitor of bacterial β-glucuronidase, specifically targeting Loop 1 (L1) in gut microbiota, with an IC50 value of 0.117 μM for E. coli β-glucuronidase. This compound effectively blocks the processing of SN-38 glucuronide, predominantly in individuals with a high abundance of L1 GUS enzymes in their fecal microbiota. Its application is of particular interest in studying gut microbiome interactions and drug metabolism. -
Bacterial Inhibitor
3-O-Methylgalangin is a natural flavonoid derived from the rhizome of Alpinia officinarum, exhibiting significant antibacterial activity. This compound acts as a bacterial inhibitor and is also known to inhibit pancreatic lipase. Its properties make it a valuable tool for research in microbiology and metabolic studies. -
Antibacterial Agent
BAY-Y 3118 is a quinolone antibacterial agent that targets bacterial DNA replication. It demonstrates broad-spectrum antibacterial activity in vitro, exhibiting high efficacy against gram-positive cocci and anaerobic bacteria. Additionally, BAY-Y 3118 shows moderate activity against Enterobacteriaceae and Pseudomonas aeruginosa. This compound is suitable for research applications related to infectious diseases and the development of new antibacterial therapies. -
Bacterial Inhibitor
Nonacosane is a naturally occurring alkane derived from Baphia massaiensis, with demonstrated antibacterial activity. It exhibits weak inhibitory effects against various bacterial strains, including Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa, and Staphylococcus aureus. This compound can be utilized in research focused on bacterial resistance and the development of antibacterial agents. -
Antibacterial Agent
Lindenenol is a bioactive compound derived from Radix linderae, known for its potent antibacterial properties. This compound exhibits significant antioxidant activity, making it suitable for research applications aimed at exploring its therapeutic potential against bacterial infections and oxidative stress-related diseases. -
Bacterial Inhibitor
5-Desmethylsinensetin is a bacterial inhibitor derived from Artemisia princeps. This compound exhibits significant antiprotozoal activity, demonstrating IC50 values of 0.4 μg/mL against T. cruzi epimastigotes and 75.1 μg/mL against trypomastigotes. It serves as a valuable tool for research into protozoan infections and potential therapeutic applications. -
Antibacterial Agent
Gancaonin G is a 6-prenylated isoflavanone with antibacterial properties, primarily targeting Streptococcus mutants and MRSA strains. This compound, isolated from Glycyrrhiza uralensis, exhibits significant antibacterial activity, making it a valuable candidate for research in antimicrobial therapies and the development of new antibiotics. Investigations into its mechanism of action can contribute to understanding resistance patterns and the efficacy of isoflavanones in combating bacterial infections. -
Bacterial Inhibitor
Salannin is a limonoid compound derived from the seed oil of Azadirachta indica, acting primarily as a bacterial inhibitor. It exhibits significant antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable reagent in microbiological research. Additionally, Salannin demonstrates antiulcer and spermicidal properties, supporting its potential applications in pharmacological studies and therapeutic development. -
Antibacterial Agent
Pradofloxacin is a third-generation fluoroquinolone antibacterial agent that primarily targets bacterial DNA gyrase and topoisomerase IV, disrupting bacterial replication and transcription. It exhibits potent activity against a wide range of gram-positive and gram-negative bacteria, making it suitable for the study of bacterial infections, particularly in veterinary medicine for conditions such as skin infections in dogs and cats. Its unique pharmacological profile allows for effective research into the management of resistant bacterial strains in animal health. -
Bacterial Inhibitor
2-Mercaptopyridine N-oxide sodium is a bacterial inhibitor targeting Mycobacterium tuberculosis. It exhibits a bactericidal effect with a minimum inhibitory concentration (MIC90) of 7.20 μM against the standard strain H37Rv (ATCC 27294). This compound, along with its complexes with iron, gallium, and bismuth, demonstrates promising anti-tuberculosis activity, indicating its potential utility in the treatment of tuberculosis. -
Antibacterial Agent
Lysicamine is a natural compound that functions as an antibacterial agent. It demonstrates significant antibacterial activity, making it a valuable tool for research in infection control and therapeutic development. Additionally, Lysicamine exhibits anticancer and anti-inflammatory properties, broadening its potential applications in the study of cancer biology and inflammatory diseases. -
Bacterial Inhibitor
4-Ethoxyphenol is a natural bacterial inhibitor derived from the marine gorgonian-associated bacterium Bacillus amyloliquefaciens SCSIO 00856. This compound exhibits significant antilarval activity, demonstrating an EC50 value of 24.1 μg/mL against Bacillus amphitrite larvae. Its properties make it a valuable tool for research applications in microbiology and biopesticide development. -
Bacterial Inhibitor
Rubrofusarin is a polyketide pigment derived from Fusarium graminearum, known for its antibacterial properties. This compound exhibits significant biological activity, including anticancer and antioxidant effects, and has been shown to alleviate depressive symptoms induced by chronic restraint stress through the PI3K/Akt signaling pathway. Rubrofusarin serves as a valuable tool in research applications focused on bacterial inhibition and the exploration of therapeutic strategies for stress-related disorders. -
Antibacterial Agent
Niridazole is an antibacterial agent targeting anaerobic and microaerophilic bacteria. It exhibits potent inhibitory activity, with IC50 values ranging from 0.0037 to 1.0 μg/mL. This compound is valuable for research applications focused on bacterial infections and assessing antimicrobial efficacy. -
Bacterial Inhibitor
N-Butanoyl-DL-homoserine lactone (Rac-C4-HSL) functions as a bacterial inhibitor by interfering with quorum sensing mechanisms. This racemic mixture includes both N-Butanoyl-D-homoserine lactone and N-Butanoyl-L-homoserine lactone, the latter being significant in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone exhibits antibacterial activity by inhibiting biofilm formation, particularly in Pseudomonas aeruginosa, making it valuable for research in bacterial communication and biofilm-related studies. -
Antibacterial Agent
PNU-101603 is a sulfoxide metabolite of Sutezolid, functioning as an antibacterial agent. It exhibits potent activity against Mycobacterium tuberculosis, effectively targeting both susceptible and multidrug-resistant strains. This compound is valuable for research applications focused on developing new therapeutic strategies for tuberculosis treatment. -
Bacterial Inhibitor
JPD447 is a potent inhibitor of the enzyme UppS, which plays a critical role in bacterial cell wall biosynthesis. By targeting this enzyme, JPD447 enhances the efficacy of β-lactam antibiotics, making it a valuable tool in combatting bacterial infections. Its application in research focuses on understanding antibiotic resistance mechanisms and improving antibiotic therapeutic strategies. -
Antibacterial Agent
Alpibectir is an antibacterial agent that targets bacterial cell proliferation. It exhibits significant antibacterial activity, making it suitable for studies focused on infection control and the mechanisms of antibiotic resistance. This compound can be utilized in research applications aimed at developing new therapeutics for bacterial infections. -
Antibacterial Agent
3-Bromo-1H-pyrrole-2,5-dione is a potent antibacterial agent targeting various pathogenic bacteria. It demonstrates significant antibacterial activity against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853, with minimum inhibitory concentration (MIC) values of 32 μg/mL, 32 μg/mL, and 64 μg/mL, respectively. This compound is useful for research purposes focused on developing new antibacterial therapies. -
Bacterial Inhibitor
4-Chloroquinaldine is a bacterial inhibitor that targets various bacterial species, demonstrating significant antibacterial activity. This compound serves as an important intermediate in chemical synthesis and research applications aimed at exploring antibiotic development and mechanisms of bacterial resistance. Its utility in microbiological studies makes it a valuable reagent for researchers in the field. -
Bacterial Inhibitor
Picloxydine is a heterocyclic biguanide that serves as a bacterial inhibitor. It exhibits significant antibacterial and antiplaque activity, making it useful in various research applications aimed at understanding microbial growth and infection control. This compound can be applied in studies related to dental hygiene and the prevention of bacterial biofilms. -
Carrier of Antibacterial Agents
Montmorillonite is a 2:1 layered clay mineral primarily acting as a carrier for antibacterial agents. Its unique structure, featuring interconnected silicon-oxygen tetrahedral and aluminum (or magnesium) hydroxide octahedral sheets, enables effective ion exchange and adsorption of bacteria. This property allows Montmorillonite to enhance the delivery of ionic antibacterial agents, making it valuable in applications related to industrial decontamination and wastewater treatment for the removal of harmful ions. -
Antibacterial Agent
1650-M15 is a selective inhibitor of lipoteichoic acid synthase (LtaS), demonstrating significant antibacterial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA). The compound exhibits IC50 values of 62.44 μM and 66.42 μM for MRSA and MSSA, respectively, with minimum inhibitory concentrations (MICs) of 200 μM for both strains. 1650-M15 serves as a valuable tool for research focused on developing novel antibacterial strategies against Gram-positive infections. -
Antibacterial Agent
Cefditoren sodium is a broad-spectrum, third-generation oral cephalosporin that primarily targets bacterial infections. It exhibits enhanced stability against various β-lactamases, allowing it to effectively combat both Gram-negative and Gram-positive organisms. Cefditoren sodium is particularly useful in research focused on infectious diseases, including acute exacerbations of chronic bronchitis, community-acquired pneumonia, streptococcal pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections. -
Antibacterial Agent
Sanguisorbigenin is a natural antibacterial compound known for its ability to inhibit methicillin-resistant Staphylococcus aureus (MRSA). This agent demonstrates significant antibacterial activity, making it a valuable tool for research focused on tackling antibiotic resistance and developing novel antimicrobial therapies. Its efficacy against resistant strains supports its potential applications in both academic and clinical microbiology studies. -
Bacterial Inhibitor
LolCDE-IN-2 is a potent inhibitor of the LolCDE protein complex, targeting bacterial lipid transport. It demonstrates significant antibacterial activity against E. coli MG1655, with a minimum inhibitory concentration (MIC) of 2 μg/ml. This compound is valuable for research applications focused on bacterial pathogenesis and antibiotic resistance mechanisms. -
Bacterial Inhibitor
Enterocin K1 is a ribosomally synthesized peptide that functions as a bacteriocin, specifically targeting Enterococcus faecalis through the Eep protein on the bacterial membrane. This compound exhibits significant antibacterial activity against vancomycin-resistant Enterococcus (VRE). Enterocin K1 is primarily utilized in research focusing on VRE infections and the mechanisms of microbial resistance, making it a valuable tool in the development of novel therapeutic strategies. -
Bacterial Inhibitor
Fmoc-Tpi-OH is a biologically active amino acid that functions as a building block for the synthesis of antimicrobial peptide mimetics. Its unique structure allows for the development of compounds with potential antibacterial properties. This reagent is essential for research applications focused on peptide chemistry, drug design, and the exploration of new antimicrobial therapies. -
Antibacterial Agent
Continentalic acid is an antibacterial agent derived from Aralia continentalis, exhibiting minimum inhibitory concentrations (MICs) of approximately 8-16 μg/mL against Staphylococcus aureus. This compound demonstrates effectiveness against both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) strains. It serves as a valuable tool for research into antibacterial therapies and the development of new treatments for resistant bacterial infections. -
Bacterial Inhibitor
Isopsoralenoside is a benzofuran glycoside derived from Psoralea corylifolia, functioning primarily as a bacterial inhibitor. This compound exhibits estrogen-like activity, promotes osteoblastic proliferation, and demonstrates antitumor effects. Isopsoralenoside's antibacterial properties make it a valuable tool for research applications aimed at exploring microbial inhibition and associated biological processes. -
Antibacterial Agent
Salazopyridazine is an antibacterial agent primarily targeting bacterial infections. It exhibits notable activity against ulcerative colitis, making it relevant for gastrointestinal research. Additionally, Salazopyridazine is utilized in studies related to rheumatic diseases, providing insights into inflammatory pathways and therapeutic strategies. -
Bacterial Inhibitor
Bixafen is a pyrazole fungicide that acts as a succinate dehydrogenase inhibitor, effectively targeting and inhibiting bacterial pathogens in cereal crops. Its broad-spectrum activity makes it a valuable tool in agricultural research, helping to elucidate mechanisms of pathogen resistance and manage crop health. Bixafen's specific inhibition of succinate dehydrogenase contributes to its efficacy in various fungicidal applications. -
Bacterial Division Inhibitor
Divin, a bacterial division inhibitor, acts as a potent chelator of iron, leading to a bacteriostatic effect against both Gram-negative and Gram-positive bacteria. This compound disrupts the assembly of late division proteins, interferes with peptidoglycan remodeling at the division site, and inhibits cytoplasmic compartmentalization. Divin is valuable for research applications focused on understanding bacterial cell division mechanisms and developing new antibacterial strategies. -
Bacterial Inhibitor
Licoricone is a flavonoid derived from licorice that serves as a bacterial inhibitor. It demonstrates significant anti-Helicobacter pylori activity against both clarithromycin- and amoxicillin-resistant strains, as well as four clarithromycin- and amoxicillin-sensitive strains. This compound is valuable for research focusing on bacterial resistance and studies aimed at developing new therapeutic strategies against H. pylori infections. -
Antibacterial Agent
Thiamphenicol glycinate hydrochloride is a broad-spectrum antibacterial agent primarily targeting bacterial protein synthesis. Its key biological activity makes it valuable for studying respiratory tract infections and various bacterial pathogens. This compound is instrumental in research applications focused on antibiotic resistance and the development of new antibacterial therapies. -
Bacterial Inhibitor
Nornidulin is a depsidone derived from Aspergillus nidulans, exhibiting significant antibacterial activity against Mycobacterium tuberculosis and Mycobacterium ranoe, as well as antifungal effects against Trichophyton tonsurans and Microsporum audouini. Additionally, it demonstrates potent inhibition of methicillin-resistant Staphylococcus aureus (MRSA) with a minimum inhibitory concentration (MIC) of 2 μg/mL. Furthermore, Nornidulin displays cytotoxicity in MOLT-3 cells with an IC50 value of 35.7 μM, while exhibiting lower toxicity against HuCCA-1, HepG2, and A549 cell lines. -
Antibacterial Agent
4-Methoxycoumarin primarily targets bacterial pathogens and exhibits notable antibacterial activity against Ralstonia solanacearum. This compound is useful for research applications focused on the development of antimicrobial agents and further understanding of bacterial resistance mechanisms. Its unique structure may provide insights into the design of novel therapeutics in the fight against bacterial infections. -
Bacterial Inhibitor
3-CPs is a serotype capsular polysaccharide that inhibits antibody-mediated bacterial killing. By interfering with the immune response, it effectively reduces the phagocytosis of encapsulated bacteria. This compound is valuable for studying bacterial pathogenesis and the mechanisms of immune evasion. 3-CPs can inform research on vaccine development and therapeutic strategies aimed at combating encapsulated bacterial infections. -
Heat-inactivated Bacterial Luciferases Inhibitor
2-Nonanone is a ketone compound that inhibits the DnaKJE-ClpB bichaperone-dependent refolding of heat-inactivated bacterial luciferases. By interacting with hydrophobic segments of heat-inactivated substrates, it competes with chaperones such as IbpAB. This compound is valuable for research into bacterial infections and the mechanisms of chaperone-mediated protein refolding. -
Antibacterial Agent
Halocarban is an antibacterial agent that targets a range of bacterial strains by disrupting cell membrane integrity. Its primary biological activity includes inhibition of bacterial growth, making it suitable for research in microbiology and potential applications in personal care products. Studies have shown its effectiveness in formulations that aim to combat odor-causing bacteria. -
Antibacterial Agent
Oleanolic aldehyde is an antibacterial agent that targets oral bacteria, specifically inhibiting the growth of Streptococcus mutans and Porphyromonas gingivalis, which are linked to dental caries and periodontal disease. The compound demonstrates minimum inhibitory concentrations (MICs) of 488 μg/mL and 250 μg/mL against these pathogens, respectively. Oleanolic aldehyde is valuable for research focused on oral health and the development of antibacterial strategies. -
Antibacterial Agent
2-Hydroxy-1-methoxyanthraquinone is an antibacterial agent derived from the stem bark of Morinda lucida Benth. It demonstrates significant antibacterial activity, making it a valuable compound for research involving microbial inhibition and the study of bacterial resistance. This compound is useful in exploring potential therapeutic applications in the field of infectious diseases. -
Bacterial Inhibitor
Ethyl Orsellinate is a lichen-derived metabolite and a derivative of lecanoric acid, primarily acting as a bacterial inhibitor. It exhibits notable antiproliferative and antitumor activities, making it useful in cancer research. The compound demonstrates significant cytotoxicity against A. salina, with an LC50 of 495 μM, indicating its potential as a bioactive agent in the study of microbial and tumor biology. -
Antibacterial Agent
Monascorubrin is an antibacterial agent derived from Monascus mycelia. It exhibits a range of biological activities, including anti-inflammatory, anti-tumor, and immunomodulatory properties. Despite its therapeutic potential, Monascorubrin has been associated with embryotoxicity, exhibiting an ED50 of 4.3 μg in chicken embryos. This compound is valuable for research on tumors and inflammatory diseases, contributing to the understanding of their underlying mechanisms. -
Antibacterial Agent
16-O-Deacetyl fusidic acid lactone is an antibacterial agent derived from fusidic acid, primarily targeting Gram-positive bacteria. This compound exhibits significant antibacterial activity, making it valuable for research applications focused on Gram-positive infections. Additionally, it is ineffective against Gram-negative bacteria, which may influence experimental design in studies relating to bacterial resistance and infection control.
